CCL28 and neoplasm: Hypoxic cancer cells can upregulate C-C motif chemokine ligand 28 (CCL28) levels via HIF-1α, stimulating the recruitment of Tregs into the tumor microenvironment and allowing cancer cells to avoid immune surveillance [33].